drugset / Trial / NCT07805356
Efficacy, Safety, and Tolerability of Encaleret in Participants With Chronic Hypoparathyroidism
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of the study is to evaluate the efficacy, safety, and tolerability of orally administered encaleret tablets in participants with chronic hypoparathyroidism (HP).
Timeline
- Start
- 2026-08-31
- Primary completion
- 2028-01
- Completion
- 2033-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Encaleret | Small molecule | — | Oral |